PDS Biotech Announces Conference Call and Webcast for 2026 First Quarter Financial Results
PDS Biotechnology Corporation announced it will host a conference call and webcast on May 13, 2026, to report its financial results for Q1 2026 and provide updates on its clinical development programs, including its lead immunotherapy candidate targeting HPV16-positive cancers.